- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Tether CEO Responds to FUD: Tether Q3 Group Equity Close to $30 Billion, with U.S. Treasury Bonds Generating Approximately $500 Million in Monthly Net Income
Ethereum's Net Supply in the Last 30 Days Has Increased by 77,380 ETH
Rayls will have its TGE on December 1st
Ethereum developers are preparing for the Fusaka upgrade on December 3rd.
Hasset: Would Be Honored to Serve as Federal Reserve Chair if Nominated by Trump
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App